Novobiocin analogues as anticancer agents
US7608594B2 · kind B2 · utility
105Cited by
1References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2005 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | May 21, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel analogues and derivatives of novobiocin are provided, including compounds having modifications to the amide side chain, coumarin ring, and sugar moieties. The compounds of the present invention are useful as heat shock protein 90 inhibitors, and may be used as anticancer and neuroprotective agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.